Perhaps the real concern is what Eli Lilly's response will be. Axiron is not a big drug for them.
- Forums
- ASX - By Stock
- ACR
- us fda is investigating the safety of trt
ACR
acrux limited
Add to My Watchlist
6.25%
!
1.5¢

us fda is investigating the safety of trt, page-23
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $6.116M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.5¢ | $1.574K | 104.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 609316 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 388346 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 609316 | 0.015 |
2 | 320000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
2 | 150000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 388346 | 2 |
0.017 | 45000 | 2 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
Last trade - 11.39am 26/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online